Press Release FeedGet the RSS feed
Menu

GlobeNewswire

NKGen Biotech to Present on Potential of Troculeucel in Neurodegenerative Diseases at Biologics Manufacturing Korea 2026

GlobeNewswire

SANTA ANA, Calif., Sept. 10, 2026 -- NKGen Biotech, Inc. (OTC: NKGN) (“NKGen” or the “Company”), a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous and allogeneic natural killer (“NK”) cell therapeutics, today announced that NKGen Chairman and Chief Executive Officer Paul Y. Song, M.D., will present on the potential of troculeucel, the Company’s lead investigational program, for the treatment of neurodegenerative diseases at Biologics Manufacturing Korea 2026, taking place September 17-18, 2026, in Incheon, South Korea.

  1. AIJames Altucher, Tech Investor WashingtonA 160-Year-Old Coal Lesson Says AI’s Power Problem Is About to Get WorseIn 1865, cheaper steam power made Britain burn more coal, not less. AI may be following the same script, and James Altucher says Elon Musk is planning for it on a scale no one else is.
  2. INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Webull Corporation (BULL) Investors with Substantial Losses May Seek to Lead Shareholder Class Action Lawsuit - December 7, 2026 DeadlineThe case alleges Webull and its top executives made false and/or misleading statements to investors.
  3. JUST Completes 5th JST Buyback & Burn: Over 170M Tokens (~$23.53M) Burned Ahead of Major Deflationary UpgradeOver the past year, JUST has completed five consecutive large-scale buyback-and-burn rounds, permanently removing 1.88B JST tokens from circulation and pushing cumulative deflation toward 19%. Following this milestone, the buyback and burn mechanism is set to undergo a comprehensive upgrade.
  4. FinanceBitTorrent Ushers in Next-Gen Web3 Infrastructure with Strategic Rebrand and Inaugural BTT BurnThe first round of BTT repurchased with decentralized service revenue has been completely burned, as BitTorrent leverages its reimagined architecture to pivot toward Web3 and AI infrastructure.
  5. FinanceROSEN, RECOGNIZED TRIAL ATTORNEYS, Encourages Anavex Life Sciences Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – AVXLWHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Anavex Life Sciences Corp. (NASDAQ: AVXL) between November 26, 2025 and August 28, 2026, both dates inclusive (the “Class Period”), of the important November 30, 2026 lead plaintiff deadline in the securities class action first filed by the Firm.
  6. Bronstein, Gewirtz & Grossman LLC Urges Netcapital Inc. Investors to Act: Class Action Filed Alleging Investor HarmNew class action for Netcapital (NCPL) urges investors to seek recovery for alleged securities fraud violations – lead plaintiff deadline of 12/7/2026